Adverum Biotechnologies
Menlo Park
About Adverum Biotechnologies
Adverum Biotechnologies is a clinical-stage company that aims to establish gene therapy as a new standard of care for a number of highly prevalent ocular diseases with the aspiration of developing functional cures for these diseases to restore vision and prevent blindness. Their services include gene therapy, biotechnology, rare diseases, ophthalmology, and retina.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $814.9M
- Funding stage: M&A
- Last round: Post-IPO Equity (Feb 2024)
- Ticker: nasdaq:ADVM
- Website: adverum.com
- Phone: +1 650 272 6269
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/adverum-biotechnologies-87505 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.